Multicomponent Intervention Study- Blood Donors With High Cholesterol

Description

The purpose and objective of this study is to improve cholesterol treatment among blood donors with FH (Familial Hypercholesterolemia).

Conditions

Lipid Metabolism Disorder

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose and objective of this study is to improve cholesterol treatment among blood donors with FH (Familial Hypercholesterolemia).

Implementing a Multicomponent Intervention to Treat Blood Donors With Familial Hypercholesterolemia

Multicomponent Intervention Study- Blood Donors With High Cholesterol

Condition
Lipid Metabolism Disorder
Intervention / Treatment

-

Contacts and Locations

Dallas

UT Southwestern Medical Center, Dallas, Texas, United States, 75390

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Blood donors from Carter BloodCare with high cholesterol meeting MEDPED FH criteria
  • * Age 18 to 75 years
  • * Currently taking medication to lower cholesterol
  • * Taking any medication that can interact with statins
  • * Pregnancy
  • * Identified secondary cause of elevated lipids
  • * Chronic liver disease or significantly elevated liver function tests (\> 3 times upper limit)

Ages Eligible for Study

18 Years to 75 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Texas Southwestern Medical Center,

Amit Khera, MD, PRINCIPAL_INVESTIGATOR, UT Southwestern Medical Center

Study Record Dates

2027-02-28